Calf serum used in manufacturing of viral vaccines: Bharat Biotech

However, the final formulation of its Covid-19 vaccine Covaxin is free from all impurities, the firm said

Topics
Bharat Biotech | Coronavirus | Coronavirus Tests

IANS  |  Hyderabad 

Bharat Biotech, Covaxin
Photo: Shutterstock

on Wednesday clarified that while new born calf serum is used in the manufacturing of viral vaccines, the final formulation of its Covid-19 vaccine Covaxin is free from all impurities.

"New born calf serum is used in the manufacturing of viral vaccines. It is used for the growth of cells, but neither used in growth of SARS CoV2 virus nor in the final formulation," the company said in a statement.

"Covaxin is is highly purified to contain only the inactivated virus components by removing all other impurities," it added.

The Hyderbad-based vaccine manufacturer clarified that bovine serum is widely used in the manufacture of vaccines globally for several decades.

It also stated that the usage of new born calf serum was transparently documented in various publications for the last 9 months.

--IANS

ms/in

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Bharat Biotech
First Published: Wed, June 16 2021. 15:35 IST
RECOMMENDED FOR YOU